Owners and management
CVR: 46458125
Not available
Kristian Kølby Kristensen (20-24,99%), Vita Sereika-Bejder (20-24,99%)
4 more
CVR · view owners
Kristian Kølby Kristensen, Kristian Strømgaard
1 more in management
CVR · view management
Active
Founded 3 May 2026
CVR · view overview
No headcount reported
Name registered: Neurophase Therapeutics ApS
CVR · 03/05/2026
View the full event history
Neurophase Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2026. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Kølby Kristensen, Kristian Strømgaard and Vita Sereika-Bejder. The company's owners include Kristian Kølby Kristensen, Vita Sereika-Bejder and Thi Kim Chi Le.
Selskabets formål er at drive forskning, udvikling og kommercialisering inden for bioteknologi og lægemiddeludvikling samt anden hermed beslægtet virksomhed.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of Neurophase Therapeutics ApS is 46458125.
The owners of Neurophase Therapeutics ApS include Kristian Kølby Kristensen, Vita Sereika-Bejder and Thi Kim Chi Le.
The management of Neurophase Therapeutics ApS consists of Kristian Kølby Kristensen, Kristian Strømgaard and Vita Sereika-Bejder.
Neurophase Therapeutics ApS was founded on 3 May 2026.
Neurophase Therapeutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Neurophase Therapeutics ApS is located at c/o BII, Ole Maaløes Vej 3, 2200 København N.
Claim this page to add your logo and social links. Free to get started.
As of May 3, 2026, Kristian Strømgaard is registered as director of Neurophase Therapeutics ApS.
As of May 3, 2026, Kristian Kølby Kristensen is registered as director of Neurophase Therapeutics ApS.
As of May 3, 2026, Vita Sereika-Bejder is registered as director of Neurophase Therapeutics ApS.
As of May 3, 2026, Kristian Kølby Kristensen is registered as an owner of Neurophase Therapeutics ApS with an ownership share of 20%.
As of May 3, 2026, Vita Sereika-Bejder is registered as an owner of Neurophase Therapeutics ApS with an ownership share of 20%.
As of May 3, 2026, Thi Kim Chi Le is registered as an owner of Neurophase Therapeutics ApS with an ownership share of 5%.
As of May 3, 2026, Jaroslava Kofoed Smolikova is registered as an owner of Neurophase Therapeutics ApS with an ownership share of 5%.
As of May 3, 2026, Alberte Vad Mathiesen is registered as an owner of Neurophase Therapeutics ApS with an ownership share of 5%.
As of May 3, 2026, KRISTIAN STRØMGAARD HOLDING ApS is registered as an owner of Neurophase Therapeutics ApS with an ownership share of 25%.
Neurophase Therapeutics ApS was founded on May 3, 2026.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 44478587
CVR 31427169
CVR 43506242
